GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) » Definitions » Net Issuance of Debt

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Net Issuance of Debt : ฿46.3 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. JSP Pharmaceutical Manufacturing (Thailand) PCL's net issuance of debt for the three months ended in Mar. 2024 was ฿3.1 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2024 was ฿46.3 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL Net Issuance of Debt Historical Data

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JSP Pharmaceutical Manufacturing (Thailand) PCL Net Issuance of Debt Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Issuance of Debt
-47.05 -32.55 -91.57 -49.41 58.16

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.05 -12.00 51.42 3.69 3.14

JSP Pharmaceutical Manufacturing (Thailand) PCL Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿46.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JSP Pharmaceutical Manufacturing (Thailand) PCL Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of JSP Pharmaceutical Manufacturing (Thailand) PCL's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) » Definitions » Net Issuance of Debt
Comparable Companies
BKK:DOD BKK:SSF BKK:NV BKK:SFP BKK:JDF BKK:LEE BKK:BIS BKK:TC BKK:SST BKK:CFRESH XSWX:NESN SHSE:603288 KHC GIS XPAR:BN SHSE:600887 SZSE:300999 HRL MKC K
Traded in Other Exchanges
N/A
Address
No. 255 and 257, Soi Sathupradit, 58, Bang Pongphang, Yannawa, Bangkok, THA, 10120
Website
https://www.jsppharma.com
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing drugs, dietary supplements, cosmetics, herbs, and dietary supplements in the form of vitamins including healthy coffee Ready. Its segments include Manufacturing and distribution of products under the customer's Brand name and Own Brand name. The majority of the revenue comes from the manufacturing and distribution of products under the customer's brand name. The Group is managed and operates principally in Thailand.

JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP) Headlines

No Headlines